MatchTx is a software company specializing in cancer informatics. Established in March 2015, MatchTx offers a Software-as-a-Service (SaaS) solution that aids researchers, oncologists, and clinical trial managers in identifying biomarkers that can predict the outcomes of cancer patients' treatments. Using patented algorithms, MatchTx's software classifies genomic and clinical data combinations to identify deep genetic signatures (known as Signatures) from reference data sets.

These Signatures help match therapeutics to cancer patients based on real patient outcomes instead of population averages. The company's technology has been validated in various tumor types, including Prostate Cancer, Biliary Tract Cancer, Sarcomas, and more. MatchTx collaborates with esteemed organizations such as M2Gen, ORIEN, Ohio State, and James Cancer Center to analyze thousands of cancer cases.

Their cloud-hosted product platform, combined with a team of healthcare IT software developers and data scientists, ensures they are ready to assist with projects, clinical trials, or patients. As a commercially available solution, MatchTx often starts with pilot projects on qualified cancer patient data studies in a shared risk manner. They also welcome collaborations with academic institutions, offering access to data sets, software tools, and grant opportunities.

The management team at MatchTx is led by seasoned executives, including Jeff Wilt (COO/CFO), who brings over 30 years of experience in managing healthcare software companies. Dr. James Chen, the inventor of the technology, serves as Director of Precision Medicine and contributes his extensive bioinformatics experience.

Dr. Jeff Spitzner, CEO, brings his expertise in scientific software and bio-technology, equity fundraising, and executive leadership to guide the company's growth and business activities. MatchTx's team of software developers, data scientists, and customer support professionals ensure excellent support for their product and customers.

With a commitment to providing personalized precision medicine using deep genetic signatures, MatchTx is dedicated to improving cancer treatment outcomes. Contact them to learn more about their innovative solutions and potential collaboration opportunities